IL17A and non-small cell lung carcinoma: Notably, the pathways that might be related to NSCLC included lipid and atherosclerosis, the TNF signaling pathway, the IL-17 signaling pathway, transcriptional misregulation in cancer, pathways in cancer, the PPAR signaling pathway, and others.